The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
Texas MPN Workshop 2022 | The importance of patient perspectives during treatment journeys
Jerry Spivak, MD, Johns Hopkins University School of Medicine, Baltimore, MD, comments on the importance of the patient’s perspective when treating those with myeloproliferative neoplasms (MPNs), and further highlights the value of engaging with and listening to patients during their treatment journey. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
